Filters
reset allOther countries
Results: 1 to 17 of 17
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
AP5Z1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 669 | 688 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
Ataxia / Spastic Paraplegia Panel Centogene AG - the Rare Disease Company Germany | 442 | 443 |
|
Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel Invitae United States | 971 | 680 |
|
Invitae Cerebral Palsy Spectrum Disorders Panel Invitae United States | 638 | 419 |
|
Complex Hereditary Spastic Paraplegia Panel PreventionGenetics, part of Exact Sciences United States | 72 | 87 |
|
Hereditary Spastic Paraplegia Comprehensive Panel PreventionGenetics, part of Exact Sciences United States | 87 | 106 |
|
Pure Hereditary Spastic Paraplegia Panel PreventionGenetics, part of Exact Sciences United States | 31 | 36 |
|
Spastic Paraplegia 48 via the AP5Z1 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Invitae Hereditary Spastic Paraplegia Comprehensive Panel Invitae United States | 98 | 62 |
|
SPASTIC PARAPLEGIA, FAMILIAL (AUTOSOMAL RECESSIVE) Laboratorio de Genetica Clinica SL Spain | 8 | 8 |
|
Athena Diagnostics United States | 40 | 24 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Fulgent Genetics United States | 53 | 27 |
|
Results: 1 to 17 of 17
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.